Worldclass care for underserved health markets
We are developing technology that applies Artificial Intelligence and novel protocols in Biomarker detection for this purpose, with a founding team of well credentialed and highly motivated biomedical science researchers who hail from Nigeria and Bangladesh and have received postgraduate degrees from the Universities of Cambridge, Manchester and Ilorin. Our research experience includes rapid diagnostic device development for tuberculosis, cost effective methods of sex chromosome anomaly detection (for Swyer syndrome) and the use of AI in improving detection of early-onset triple-negative breast cancer (TNBC).
Our pioneer product is targeted at maternal care sector of healthcare. We have invented a diagnostic device that facilitates early detection of biological conditions that may cause miscarriages and preterm births (colloquially called premature births), thus, giving pregnant women a chance at preventing it.
The A Team
Mkpouto Udo Pius
Chief Executive Officer
Chief Operations Officer
Chief Technology Officer
News & Event
Biomasys Chief Technology Officer Nusrat Rouf discuses HealtiPreg and potential collaboration with governments to combat maternal mortality.
Biomasys accepted into the prestigious Accelerate programme at the University of Cambridge.
Biomasys co-founder recognised as one of the top 10 promising entrepreneurs in Bangladesh.
Electronic Health Record Management continues to be an important tool in the improvement of healthcare as it spreads across continents. #healthcare #management #Biomasys #Maximon #health https://t.co/R8i2Afqd9PRead More
This award supported has aided incredible advancement of our project Maximon and we would love to thank Satander for these invaluable opportunities. Watch out for our Maximon. #opportunities #project #biomasys #maximon #santanderRead More
We at Biomasys are proud to announce that we are a recipient of the £2,500 Santander Accelerate Cambridge Project roject Award. See thread for more 👇 #opportunities #project #biomasys #maximon #santander https://t.co/Uu9YPckTyFRead More
At Biomasys, we are developing Healtipreg which is a rapid, point of care diagnostic device that can predict miscarriages and premature birth. Would you like to learn more or support? Visit today. #biomasys #healtipreg #healthcareRead More